Monday, 18 March 202400:00 |  | Conference Chair Title to be Confirmed.
Steve Soper, Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas, United States of America
|
| 00:00 |  | Keynote Presentation Title to be Confirmed.
Erik Vollebregt, Partner, Axon Lawyers, Netherlands
|
| 00:00 |  | Keynote Presentation Title to be Confirmed.
Paul Bohn, Arthur J. Schmitt Professor of Chemical and Biomolecular Engineering and Professor of Chemistry and Biochemistry, University of Notre Dame, United States of America
|
| 00:00 |  | Keynote Presentation Title to be Confirmed.
Hsian-Rong Tseng, Professor, Crump Institute for Molecular Imaging, California NanoSystems Institute, University of California-Los Angeles, United States of America
|
| 00:00 |  | Keynote Presentation Title to be Confirmed.
Brian Cunningham, Professor and Intel Alumni Endowed Chair, University of Illinois at Urbana-Champaign, United States of America
|
| 00:00 |  | Keynote Presentation Title to be Confirmed.
Martyn Boutelle, Professor of Biomedical Sensors Engineering, Imperial College London, United Kingdom
|
| 00:00 |  | Keynote Presentation Title to be Confirmed.
Yoon-Kyoung Cho, Professor, Biomedical Engineering, Ulsan National Institute of Science & Technology; Group leader, IBS; FRSC, Fellow of Royal Society of Chemistry, Korea South
|
| 00:00 | Title to be Confirmed.
Hyungsoon Im, Assistant Professor, Center for Systems Biology, Mass General Hospital (MGH)/Harvard Medical School, United States of America
| 00:00 |  | Keynote Presentation Title to be Confirmed.
Daniel Chiu, A. Bruce Montgomery Professor of Chemistry, University of Washington, United States of America
|
| 00:00 |  | Keynote Presentation Title to be Confirmed.
David Wong, Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles, United States of America
|
| 00:00 |  | Keynote Presentation Title to be Confirmed.
Andrew Godwin, Professor and Division Director, Genomic Diagnostics, Founding Director, Kansas Institute for Precision Medicine, Deputy Director, KU Cancer Center, University of Kansas Medical Center, United States of America
|
|
|
Add to Calendar ▼2024-03-18 00:00:002024-03-19 00:00:00Europe/LondonEmerging Technologies and Paradigms for In Vitro Dx Europe 2024Emerging Technologies and Paradigms for In Vitro Dx Europe 2024 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
